Injectable Opioids Treatment: Evidence to support its expansion in BC

Dr. Scott MacDonald, MD
Physician Lead, Providence Crosstown Clinic

Dr. Eugenia Oviedo-Joekes
Associate Professor, School of Population and Public Health, UBC

 

This talk is open to the public
A light lunch will be served

Dr. Scott MacDonald is the physician lead at the Providence Crosstown Clinic in downtown Vancouver, British Columbia. He began his work with substance use disorders in the Canadian Navy at CFB Halifax. For the past decade he has worked on the NAOMI and SALOME studies investigating intensified treatment options for street opioid and heroin users.

Eugenia Oviedo-Joekes is an Associate Professor at the School of Population and Public Health at the University of British Columbia. Her main research area is in Public Health and Addictions, focusing on testing alternative approaches to expand and diversify treatments for vulnerable populations. She currently leads a clinical trial testing injectable opioids in supervised clinics for long-term opioid dependency.

Eventbrite - Forefront Lectures

For more information, please contact education@cfenet.ubc.ca / local 66255



Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below